Hefti F - Search Results

1

The staurosporine-like compound L-753,000 (NB-506) potentiates the neurotrophic effects of neurotrophin-3 by acting selectively at the TrkA receptor.

Pollack S, Young L, Bilsland J, Wilkie N, Ellis S, Hefti F, Broughton H, Harper S. Pollack S, et al. Among authors: hefti f. Mol Pharmacol. 1999 Jul;56(1):185-95. doi: 10.1124/mol.56.1.185. Mol Pharmacol. 1999. PMID: 10385700

2

The non-peptidyl fungal metabolite L-783,281 activates TRK neurotrophin receptors.

Wilkie N, Wingrove PB, Bilsland JG, Young L, Harper SJ, Hefti F, Ellis S, Pollack SJ. Wilkie N, et al. Among authors: hefti f. J Neurochem. 2001 Sep;78(5):1135-45. doi: 10.1046/j.1471-4159.2001.00504.x. J Neurochem. 2001. PMID: 11553687 Free article.

3

Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neurons.

Bilsland J, Roy S, Xanthoudakis S, Nicholson DW, Han Y, Grimm E, Hefti F, Harper SJ. Bilsland J, et al. Among authors: hefti f. J Neurosci. 2002 Apr 1;22(7):2637-49. doi: 10.1523/JNEUROSCI.22-07-02637.2002. J Neurosci. 2002. PMID: 11923429 Free PMC article.

4

Analysis of the neurotrophic effects of GPI-1046 on neuron survival and regeneration in culture and in vivo.

Harper S, Bilsland J, Young L, Bristow L, Boyce S, Mason G, Rigby M, Hewson L, Smith D, O'Donnell R, O'Connor D, Hill RG, Evans D, Swain C, Williams B, Hefti F. Harper S, et al. Among authors: hefti f. Neuroscience. 1999 Jan;88(1):257-67. doi: 10.1016/s0306-4522(98)00221-8. Neuroscience. 1999. PMID: 10051205

5

CEP-1347 increases ChAT activity in culture and promotes cholinergic neurone survival following fimbria-fornix lesion.

Harper SJ, Saporito MS, Hewson L, Young L, Smith D, Rigby M, Jackson P, Curtis N, Swain C, Hefti F, Vaught JL, Sirinathsinghji D. Harper SJ, et al. Among authors: hefti f. Neuroreport. 2000 Jul 14;11(10):2271-6. doi: 10.1097/00001756-200007140-00041. Neuroreport. 2000. PMID: 10923684

6

Pharmacology of neurotrophic factors.

Hefti F. Hefti F. Annu Rev Pharmacol Toxicol. 1997;37:239-67. doi: 10.1146/annurev.pharmtox.37.1.239. Annu Rev Pharmacol Toxicol. 1997. PMID: 9131253 Review.

7

Trophic effect of exogenous nerve growth factor on rat striatal cholinergic neurons: comparison between intraparenchymal and intraventricular administration.

Venero JL, Hefti F, Knusel B. Venero JL, et al. Among authors: hefti f. Mol Pharmacol. 1996 Feb;49(2):303-10. Mol Pharmacol. 1996. PMID: 8632763

8

K-252b selectively potentiates cellular actions and trk tyrosine phosphorylation mediated by neurotrophin-3.

Knüsel B, Kaplan DR, Winslow JW, Rosenthal A, Burton LE, Beck KD, Rabin S, Nikolics K, Hefti F. Knüsel B, et al. Among authors: hefti f. J Neurochem. 1992 Aug;59(2):715-22. doi: 10.1111/j.1471-4159.1992.tb09427.x. J Neurochem. 1992. PMID: 1629741

9

Characterization of a multicomponent receptor for GDNF.

Treanor JJ, Goodman L, de Sauvage F, Stone DM, Poulsen KT, Beck CD, Gray C, Armanini MP, Pollock RA, Hefti F, Phillips HS, Goddard A, Moore MW, Buj-Bello A, Davies AM, Asai N, Takahashi M, Vandlen R, Henderson CE, Rosenthal A. Treanor JJ, et al. Among authors: hefti f. Nature. 1996 Jul 4;382(6586):80-3. doi: 10.1038/382080a0. Nature. 1996. PMID: 8657309

10

Neurotrophin-3 reverses experimental cisplatin-induced peripheral sensory neuropathy.

Gao WQ, Dybdal N, Shinsky N, Murnane A, Schmelzer C, Siegel M, Keller G, Hefti F, Phillips HS, Winslow JW. Gao WQ, et al. Among authors: hefti f. Ann Neurol. 1995 Jul;38(1):30-7. doi: 10.1002/ana.410380108. Ann Neurol. 1995. PMID: 7611721

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

437 results

Search Page

Filters